We are currently importing the latest prescribing data. You may see incomplete data across the site. Please check back in a couple of hours!

VMP 42353011000001103

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Dicycloverine 10mg tablets
BNF code 0102000J0AAABAB
Virtual Therapeutic Moiety Dicycloverine
Date identifier became valid 20 Oct 2023
Previous product identifier 317109009
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 1 Dec 2003
Previous name Dicyclomine 10mg tablets
Basis of previous name BAN - British Approved Name
Reason for name change Basis of name changed
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Non-availability Actual Products Available
Non-availability status date 6 Jul 2011
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Dicycloverine hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 10.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Dicycloverine 10mg tablets (A A H Pharmaceuticals Ltd)
Dicycloverine 10mg tablets (Alliance Healthcare (Distribution) Ltd)
Dicycloverine 10mg tablets (Flamingo Pharma (UK) Ltd)
Dicycloverine 10mg tablets (Medihealth (Northern) Ltd)
Dicycloverine 10mg tablets (Morningside Healthcare Ltd)
Dicycloverine 10mg tablets (Phoenix Healthcare Distribution Ltd)
Dicycloverine 10mg tablets (Sigma Pharmaceuticals Plc)
Dicycloverine 10mg tablets (Teva UK Ltd)
Dicycloverine 10mg tablets (Zentiva Pharma UK Ltd)
Virtual Medicinal Product Packs
Dicycloverine 10mg tablets 100 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback